Product verification is particularly important for prescription oncology medicines. A product should not be assumed to be authentic solely because its packaging looks professional or contains a barcode, QR code or batch number.
Information to compare
Check the package against reliable documentation for:
- Product name
- Active ingredient
- Strength
- Dosage form
- Manufacturer
- Batch or lot number
- Expiry date
- Country-specific authorization information
- Patient information leaflet
- Packaging integrity
- Tamper-evident features
Erdanib-specific verification
The manufacturer and regulatory authorization of the specific Erdanib product have not been independently established from the available documentation.
Erdanib authentication system: [Information requires verification]
No specific QR-code, serial-number portal or online authentication database should be claimed without manufacturer or regulator documentation.
Reference-product comparison
Current U.S. BALVERSA packaging identifies erdafitinib tablets and lists specific NDC information and Janssen Products LP as packager. This information should not be used to authenticate an unrelated Erdanib product.
If a package appears suspicious
Do not rely on the medicine if there is a serious concern about its identity, packaging integrity or source. A pharmacist, healthcare professional, authorized supplier or relevant medicines regulator can provide appropriate verification guidance.
Counterfeit medicine awareness
Falsified medicines can contain the wrong active ingredient, incorrect strength, contaminants or no active ingredient. Supply through legitimate pharmaceutical channels is an important part of reducing this risk.